Suppr超能文献

冠心精胶囊治疗冠心病合并抑郁症的主要活性成分鉴定。

Main active constituent identification in Guanxinjing capsule, a traditional Chinese medicine, for the treatment of coronary heart disease complicated with depression.

机构信息

Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.

The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine, Changsha 410007, China.

出版信息

Acta Pharmacol Sin. 2018 Jun;39(6):975-987. doi: 10.1038/aps.2017.117. Epub 2017 Aug 31.

Abstract

Guanxinjing capsules (GXJCs) are used in traditional Chinese medicine as a common therapy for coronary heart disease (CHD) complicated with depression. In this study, we aimed to identify the main active constituents in GXJCs and to investigate the mechanisms of GXJC action on CHD complicated with depression. The chemical constituent profile of the GXJC was identified by UHPLC-LTQ-Orbitrap assay, and oral bioavailability was evaluated to screen the GXJC drug-like chemical constituents. A total of 16 GXJC drug-like chemical constituents were identified. Then, putative targets of the GXJC drug-like chemical constituents were predicted using MedChem Studio, with 870 genes found to be the putative targets of these molecules. After that, a GXJC putative target-known CHD/depression therapeutic target network was constructed, and four topological features, including degree, betweenness, closeness and K-coreness, were calculated. According to the topological feature values of the GXJC putative targets, 14 main active constituents were identified because their corresponding putative targets had topological importance in the GXJC putative target-known CHD/depression therapeutic target network, which were defined as the candidate targets of GXJC against CHD complicated with depression. Functionally, these candidate targets were significantly involved in several CHD/depression-related pathways, including repairing pathological vascular changes, reducing platelet aggregation and inflammation, and affecting patient depression. This study identified a list of main active constituents of GXJC acting on CHD complicated with depression using an integrative pharmacology-based approach that combined active chemical constituent identification, drug target prediction and network analysis. This method may offer an efficient way to understand the pharmacological mechanisms of traditional Chinese medicine prescriptions.

摘要

冠心静胶囊(GXJCs)在中医中被用作治疗冠心病(CHD)合并抑郁症的常用疗法。在这项研究中,我们旨在确定 GXJCs 的主要活性成分,并研究 GXJC 对 CHD 合并抑郁症作用的机制。采用 UHPLC-LTQ-Orbitrap 分析鉴定 GXJC 的化学成分特征,并评估口服生物利用度以筛选 GXJC 类药物化学成分。共鉴定出 16 种 GXJC 类药物化学成分。然后,使用 MedChem Studio 预测 GXJC 类药物化学成分的潜在靶点,发现 870 个基因是这些分子的潜在靶点。之后,构建了 GXJC 潜在靶点-已知 CHD/抑郁症治疗靶点网络,并计算了四个拓扑特征,包括度、介数、紧密性和 K 核。根据 GXJC 潜在靶点的拓扑特征值,确定了 14 种主要活性成分,因为它们对应的潜在靶点在 GXJC 潜在靶点-已知 CHD/抑郁症治疗靶点网络中具有拓扑重要性,被定义为 GXJC 对抗 CHD 合并抑郁症的候选靶点。功能上,这些候选靶点显著参与了几种 CHD/抑郁症相关途径,包括修复病理性血管变化、减少血小板聚集和炎症,以及影响患者抑郁。本研究采用基于整合药理学的方法,结合活性化学成分鉴定、药物靶点预测和网络分析,确定了 GXJC 作用于 CHD 合并抑郁症的主要活性成分列表。这种方法可能为理解中药方剂的药理学机制提供一种有效的途径。

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验